开立医疗
(300633)
| 流通市值：159.21亿 | | | 总市值：159.21亿 |
| 流通股本：4.31亿 | | | 总股本：4.31亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,774,621,016.57 | 1,638,710,073.63 | 1,619,051,769.22 | 1,504,411,692.77 |
| 应收票据及应收账款 | 174,224,263.72 | 172,175,242.44 | 214,257,529.57 | 182,554,445.73 |
| 其中：应收票据 | - | 326,486.26 | 3,200,390.71 | 3,987,654.46 |
| 应收账款 | 174,224,263.72 | 171,848,756.18 | 211,057,138.86 | 178,566,791.27 |
| 预付款项 | 55,331,152.37 | 53,833,512.28 | 51,497,461.55 | 47,133,186.19 |
| 其他应收款合计 | 11,570,420.03 | 16,713,014.36 | 7,422,222.52 | 12,921,183.34 |
| 存货 | 531,476,404.12 | 592,732,503.82 | 531,534,332.16 | 544,789,204.09 |
| 一年内到期的非流动资产 | 7,158,250 | 9,345,625 | 8,459,750 | 7,144,000 |
| 其他流动资产 | 19,624,488.71 | 14,018,872 | 12,662,365.19 | 6,447,892.86 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,625,395,995.52 | 2,606,668,642.53 | 2,592,025,229.21 | 2,633,566,082.4 |
| 非流动资产: | | | | |
| 长期应收款 | 14,458,930.24 | 11,877,950.11 | 15,206,268.19 | 13,945,743.51 |
| 其他权益工具投资 | 8,202,777 | 8,202,777 | 8,202,777 | 8,202,777 |
| 固定资产 | 419,545,760.99 | 391,670,122.39 | 382,986,677.17 | 384,481,329.94 |
| 在建工程 | 254,203,561.52 | 223,621,317.49 | 202,791,284.02 | 183,517,530.49 |
| 使用权资产 | 46,145,493.51 | 33,133,166.25 | 34,697,840.64 | 36,274,677.35 |
| 无形资产 | 164,854,790.33 | 163,394,800.78 | 165,500,854.87 | 167,091,238.67 |
| 商誉 | 165,899,049.19 | 183,648,081.33 | 184,744,571.96 | 178,518,412.13 |
| 长期待摊费用 | 17,929,077.74 | 12,962,966.42 | 12,520,558.8 | 12,968,506.5 |
| 递延所得税资产 | 30,601,841.92 | 35,493,598.73 | 38,661,546.85 | 37,259,737.87 |
| 其他非流动资产 | 24,179,816.87 | 42,749,223.03 | 55,404,564.19 | 36,632,902.59 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,146,021,099.31 | 1,106,754,003.53 | 1,100,716,943.69 | 1,058,892,856.05 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,771,417,094.83 | 3,713,422,646.06 | 3,692,742,172.9 | 3,692,458,938.45 |
| 流动负债: | | | | |
| 短期借款 | 23,628,320.07 | 104,240,583.33 | 154,361,416.67 | 230,509,110.55 |
| 交易性金融负债 | 1,565,542.46 | 11,963,153.91 | 18,625,012.05 | 763,342.3 |
| 应付票据及应付账款 | 186,145,110.95 | 196,902,201.13 | 192,028,513.82 | 189,243,145.26 |
| 其中：应付票据 | - | 4,043,486.04 | 1,326,028.9 | 1,175,279.3 |
| 应付账款 | 186,145,110.95 | 192,858,715.09 | 190,702,484.92 | 188,067,865.96 |
| 合同负债 | 44,592,473.23 | 56,189,265.08 | 55,291,536.78 | 97,036,308.32 |
| 应付职工薪酬 | 170,492,881.54 | 116,264,701.86 | 97,377,923.65 | 71,181,248.69 |
| 应交税费 | 38,891,638.12 | 38,890,914.99 | 43,115,868.06 | 39,919,643.56 |
| 其他应付款合计 | 82,900,707.78 | 63,468,193.61 | 63,453,070.74 | 62,652,112.15 |
| 一年内到期的非流动负债 | 14,808,514.68 | 8,313,073.49 | 11,394,081.77 | 10,950,565.33 |
| 其他流动负债 | 5,599,709.45 | 3,691,823.48 | 3,661,073.71 | 7,483,552.89 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 568,624,898.28 | 599,923,910.88 | 639,308,497.25 | 709,739,029.05 |
| 非流动负债: | | | | |
| 租赁负债 | 34,007,440.07 | 26,646,691.63 | 25,481,985.83 | 26,176,616.25 |
| 递延收益 | 22,831,105.2 | 26,725,540.62 | 27,064,121.82 | 25,874,633.71 |
| 递延所得税负债 | - | 790,829.47 | 838,524.64 | 997,025.44 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 56,838,545.27 | 54,163,061.72 | 53,384,632.29 | 53,048,275.4 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 625,463,443.55 | 654,086,972.6 | 692,693,129.54 | 762,787,304.45 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 430,652,785 | 430,652,785 | 430,652,785 | 430,652,785 |
| 资本公积 | 1,118,989,432.68 | 1,104,240,704.06 | 1,097,713,344.8 | 1,087,038,217.2 |
| 减:库存股 | 59,992,347.23 | - | - | - |
| 其他综合收益 | 23,781,742.08 | 25,786,271.35 | 20,584,302.81 | 17,949,979.24 |
| 盈余公积 | 203,824,055.73 | 153,612,731.38 | 153,612,731.38 | 153,612,731.38 |
| 未分配利润 | 1,428,697,983.02 | 1,345,043,181.67 | 1,297,485,879.37 | 1,240,417,921.18 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,145,953,651.28 | 3,059,335,673.46 | 3,000,049,043.36 | 2,929,671,634 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,145,953,651.28 | 3,059,335,673.46 | 3,000,049,043.36 | 2,929,671,634 |
| 负债和股东权益合计 | 3,771,417,094.83 | 3,713,422,646.06 | 3,692,742,172.9 | 3,692,458,938.45 |
| 公告日期 | 2024-04-12 | 2023-10-26 | 2023-08-23 | 2023-04-27 |
| 审计意见(境内) | 标准无保留意见 | | | |